Location: Home
  • search
  • go
  • Relate News
  • 6/20/2025Simcere Gains Approval to Market Insomnia Drug Quviviq in China
  • 6/20/2025MindRank's Oral GLP-1RA MDR-001 Achieves Promising Phase IIb Results i...
  • 6/20/2025Recent Executive Moves
  • 6/19/2025China's Biotech Boom Forces U.S. Pharma to Weigh Innovation Against Es...
  • 6/19/2025Chinese Biopharma Firms Reroute Supply Chains and R\&D Amid Escalating...
  • 6/18/2025EpimAb's HKEX IPO Application Accepted, Prospectus Now Published
  • 6/18/2025GenMedicn Secures Series B Funding to Fuel Gene Therapy Pipeline for ...
  • 6/17/2025Merck's Long-Acting RSV Antibody Clesrovimab Recommended for Priority ...
  • 6/17/2025China Emerges as Prime Global Target for Multinationals in Biotech Dea...
  • 6/16/2025NextCure and Simcere Zaiming Announce Strategic Partnership for a Nove...
  • 6/16/2025Merck's Keytruda Gains NMPA Approval in China for Advanced Liver Cance...
  • 6/14/2025Keymed Biosciences' BsAb Shows Promise in Autoimmune Hemolytic Anemia
  • 6/14/2025Tianjin Slaps CNY 362M Fine for Drug Price-Fixing Scheme
  • 6/13/2025Abbisko Therapeutics' Pimicotinib Earns NMPA Nod for TGCT NDA Review
  • 6/13/2025China Issues 2025 Action Plan to Combat Malpractice in Pharma Procure...
  • 6/13/2025Recent Executive Moves
  • 6/11/20253Sbio Powers Ahead in PD-1/VEGF Bispecific Race with Impressive Phase ...
  • 6/11/2025Ligachem Inks Dual ADC Licensing Deals with CSPC Subsidiary Novarock
  • 6/11/2025JW Pharma Wins China Approval for Ertapenem Injection
  • 6/11/2025MediLink Therapeutics Lines Up Major Banks for Hong Kong IPO Push
  • 6/10/2025Green Valley Halts Sales of Alzheimer's Drug GV-971 Amid Regulatory Un...
  • 6/10/2025NH's DB6: China's Consumer Healthcare Market Underperformed Again in 2...
  • 6/10/2025Merck KGaA's Pimicotinib NDA Accepted by CDE in China, Setting Course ...
  • 6/10/2025Pfizer CEO Highlights Chinese Data Due Diligence to Support $6B Bispec...
  • 6/10/2025BIOSeedin 2025 Showcases China's Rise as Global Biotech Innovator
  • 6/9/2025China Exempts U.S. Drugs & Medical Supplies from Retaliatory Tariffs
  • 6/7/2025Recent Executive Moves
  • 6/6/2025Akeso's Cadonilimab Gains First-Line Approval in Cervical Cancer in Ch...
  • 6/6/2025Keymed Launches First-in-Human Trial of CM518D1
  • 6/6/2025AstraZeneca's Imfinzi Approved in China for LS‑SCLC
  • Page:13/371 Total number of articles:11127: [First][<<] [11] [12] [13] [14] [15] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group